Circulating miRNA-155 as a Potential Biomarker for Coronary Slow Flow
Authors:
Open Access
- 25 June 2018
- journal article
- research article
- Published by Wiley in Disease Markers
- Vol. 2018, 1-6
Abstract
Objective. Recent studies have demonstrated that miRNA-155 is involved in the occurrence and development of atherosclerosis. Furthermore, miRNA-155 has emerged as a new indirect marker for inflammation associated with adverse outcomes in oncology and cardiovascular diseases. This study investigated the correlation between the levels of miRNA-155 and coronary slow flow (CSF). Methods. A total of 66 patients with CSF and 66 patients with normal coronary flow were enrolled in this study. Coronary flow velocity was determined using the thrombolysis in myocardial infarction frame count (TFC) method. The plasma levels of miRNA-155 were quantified using real-time quantitative polymerase chain reaction. Results. The plasma levels of miRNA-155 were significantly higher in the CSF group compared to the control group (). In addition, miRNA-155 levels were positively correlated with TFC and high-sensitivity C-reactive protein (hs-CRP) levels ( for both parameters). Multivariate linear regression analysis demonstrated that plasma miRNA-155 (OR = 2.384, 95% confidence interval 1.847–3.273, ) and hs-CRP (OR = 1.273, 95% confidence interval 1.036–2.253, ) were independent predictors for CSF. Using plasma miRNA-155 levels as the test variable, ROC curve analysis indicated that the area under the curve was 0.782 (). Conclusion. Patients with CSF have higher plasma levels of miRNA-155, and this may play an important role in the pathogenesis of CSF, and an elevated plasma miRNA-155 level may be a predictor for CSF. A large-scale and multicenter study is required to elucidate the role of miRNA-155 as a potential biomarker for patients with CSF.
Keywords
Funding Information
- Natural Science Foundation of Guangxi Province (2016GXNSFBA380022, 81600283)
- National Natural Science Foundation of China (2016GXNSFBA380022, 81600283)
This publication has 26 references indexed in Scilit:
- MicroRNAs in Cardiovascular DiseaseJACC, 2016
- The role of miR-126 in embryonic angiogenesis, adult vascular homeostasis, and vascular repair and its alterations in atherosclerotic diseaseJournal of Molecular and Cellular Cardiology, 2016
- MiRNA-155 targets myosin light chain kinase and modulates actin cytoskeleton organization in endothelial cellsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2014
- Coronary artery ectasia is related to coronary slow flow and inflammatory activationAtherosclerosis, 2014
- Inverse correlation between coronary and retinal blood flows in patients with normal coronary arteries and slow coronary blood flowAtherosclerosis, 2014
- Coronary Slow FlowCirculation Journal, 2012
- Early sign of atherosclerosis in slow coronary flow and relationship with angiotensin-converting enzyme I/D polymorphismHeart and Vessels, 2007
- Slow Coronary Flow: A Distinct Angiographic Subgroup in Syndrome XAngiology, 2001
- Endothelin release: a marker for the severity of exercise-induced ischemiaInternational Journal of Cardiology, 2001
- Slow coronary flow: Clinical and histopathological features in patients with otherwise normal epicardial coronary arteriesCatheterization and Cardiovascular Diagnosis, 1996